ALPMF - Astellas Pharma GAAP EPS of ¥103.03 revenue of ¥1296.16B beats by ¥1285.85B April, 27 2022 07:52 AM Astellas Pharma Inc Astellas Pharma press release (OTCPK:ALPMF): FY GAAP EPS of ¥103.03. Revenue of ¥1296.16B (+3.7% Y/Y) beats by ¥1285.85B. For further details see: Astellas Pharma GAAP EPS of ¥103.03, revenue of ¥1296.16B beats by ¥1285.85B